Fabio Maggio

Fabio Maggio
Fabio Maggio is a senior researcher of the Biomedicine Research Program. His main interests regard applications of genomics, system biology and scientific calculus to translational and personalized medicine. Over the past few years he has mainly worked on the computational prediction of drug cardiac toxicity within Predict, an European Consortium between pharma industry and academia, including the University of Oxford.
More recently, his activity has been devoted to the investigation of molecular biomarkers for oncological disease, in particular in the field of hematology. For CRS4 he promoted a collaboration agreement with the Hospital: Ospedale Oncologico di Cagliari "A. Businco" - the reference center of regione Sardegna for neoplastic pathologies. This collaboration focuses on the investigation of genomic markers for diagnosis and on patient stratification for Diffuse large B-cell lymphoma (DLBCL) and Chronic Lymphoid Leukemia (CLL).
He has been the scientist responsible, at CRS4, for several european and national research projects, as well as of industrial collaborations with national/international partners.
Position

Researcher

Contacts

Email

maggio@crs4.it

Phones

Fax

Google Scholar

e3c3ecfc-99fc-1032-95fe-0030485a3848

Publications


Projects


Questo sito utilizza cookie tecnici e assimilati. Possono essere presenti anche cookie profilazione di terze parti. Se vuoi saperne di piĆ¹ o negare il consenso a tutti o ad alcuni cookie leggi l'informativa completa. Proseguendo nella navigazione (anche con il semplice scrolling) acconsenti all'uso dei cookie. This site uses technical and anonymized analytics cookies only. There may also be profiling third-party cookies. Please read the cookie information page to learn more about how we use cookies or blocking them. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close